Stockscreener 앱 받기
6.18%
시간 외 거래:
전일 마감가:
$3.56
열려 있는:
$3.59
하루 거래량:
2.65M
Relative Volume:
0.47
시가총액:
$333.61M
수익:
$409.00K
순이익/손실:
$-101.35M
주가수익비율:
-2.3049
EPS:
-1.64
순현금흐름:
$-71.49M
1주 성능:
-1.31%
1개월 성능:
+3.00%
6개월 성능:
-33.92%
1년 성능:
-40.85%
1일 변동 폭
$3.55
$3.79
1주일 범위
$3.535
$3.84
52주 변동 폭
$2.90
$11.16
알티뮨 Stock (ALT) Company Profile
명칭
Altimmune Inc
전화
(240) 654-1450
주소
910 CLOPPER ROAD, GAITHERSBURG, MD
ALT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ALT
Altimmune Inc
|
3.78 | 314.20M | 409.00K | -101.35M | -71.49M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
알티뮨 Stock (ALT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-10 | 재개 | Goldman | Sell |
| 2025-02-28 | 개시 | William Blair | Mkt Perform |
| 2025-01-08 | 개시 | Stifel | Buy |
| 2024-11-12 | 개시 | UBS | Buy |
| 2024-04-29 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2024-01-24 | 개시 | Goldman | Neutral |
| 2023-03-22 | 다운그레이드 | Goldman | Buy → Neutral |
| 2022-12-01 | 개시 | Goldman | Buy |
| 2021-12-29 | 재개 | Jefferies | Buy |
| 2021-06-02 | 개시 | H.C. Wainwright | Buy |
| 2021-02-11 | 개시 | Guggenheim | Buy |
| 2020-12-14 | 개시 | Jefferies | Buy |
| 2020-11-12 | 재확인 | B. Riley Securities | Buy |
| 2020-09-25 | 개시 | B. Riley FBR | Buy |
| 2020-08-14 | 개시 | Evercore ISI | Outperform |
| 2020-07-31 | 개시 | Piper Sandler | Overweight |
| 2020-07-28 | 개시 | JMP Securities | Mkt Outperform |
| 2020-02-24 | 재개 | ROTH Capital | Buy |
| 2019-07-19 | 개시 | ROTH Capital | Buy |
| 2017-10-09 | 개시 | Piper Jaffray | Overweight |
모두보기
알티뮨 주식(ALT)의 최신 뉴스
How high can Altimmune Inc. stock goPortfolio Value Summary & Intraday High Probability Setup Alerts - Newser
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - Morningstar
The Risks of Over-Optimism in Telecommunications: A Case Study of Unicycive Therapeutics and Charter Communications Class-Action Allegations - AInvest
Securities Fraud Class Action Filed Against Altimmune, Inc. (ALT)Levi & Korsinsky Reminds Investors of October 6, 2025 - ACCESS Newswire
Lost Money on Altimmune, Inc. (ALT)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky - GlobeNewswire Inc.
ROSEN, LEADING INVESTOR COUNSEL, Encourages Altimmune, Inc. - GlobeNewswire
Will Altimmune Inc. outperform the market2025 Technical Overview & Safe Swing Trade Setups - Newser
ROSEN, LEADING INVESTOR COUNSEL, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
ALT LAWSUIT ALERT: Levi & Korsinsky Notifies Altimmune, Inc. InvestorsLead Plaintiff Deadline October 6, 2025 - ACCESS Newswire
Securities Class Action Lawsuit Filed Against Altimmune, Inc. (ALT)Levi & Korsinsky Represents Shareholders - ACCESS Newswire
Levi & Korsinsky Reminds Altimmune, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 6, 2025ALT - WV News
What recovery options are there for Altimmune Inc.July 2025 Trends & Free Low Drawdown Momentum Trade Ideas - Newser
Using data models to predict Altimmune Inc. stock movementJuly 2025 Trends & Consistent Profit Trade Alerts - Newser
Altimmune, Inc. Sued for Securities Law Violations - GlobeNewswire
Will Altimmune Inc. see short term momentumJuly 2025 PostEarnings & Weekly Watchlist for Hot Stocks - Newser
Lost Money on Altimmune, Inc.(ALT)? Join Class Action Suit Seeking RecoveryContact The Gross Law Firm - PR Newswire
ALT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Altimmune - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Altimmune, Inc. of Class Action Lawsuit and Upcoming DeadlinesALT - PR Newswire
Bragar Eagel & Squire, P.C. Reminds Investors of Novo, - GlobeNewswire
Investors in Altimmune, Inc. (ALT): Protect Your RightsContact Levi & Korsinsky Before October 6, 2025 - ACCESS Newswire
Securities Lawsuit Alert: Altimmune, Inc. (ALT)Contact Levi & Korsinsky Before October 6, 2025 - ACCESS Newswire
Will breakout in Altimmune Inc. lead to full recoveryJuly 2025 Trends & Safe Investment Capital Preservation Plans - Newser
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
What MACD signals say about Altimmune Inc.Quarterly Portfolio Review & Risk Managed Investment Strategies - Newser
Identifying reversal signals in Altimmune Inc.July 2025 Setups & Fast Entry Momentum Trade Alerts - Newser
Altimmune, Inc. (ALT) LawsuitInvestors Urged to Contact Levi & Korsinsky Before October 6, 2025 - ACCESS Newswire
Will Altimmune Inc. price bounce be sustainableWeekly Gains Summary & Weekly Breakout Stock Alerts - Newser
SHAREHOLDER ALERT: Berger Montague Reminds Altimmune, Inc. (NASDAQ: ALT) Investors of Class Action Lawsuit Deadline - Eastern Progress
Is Altimmune Inc. stock bottoming out2025 Year in Review & Risk Controlled Swing Trade Alerts - Newser
Shareholders of Altimmune, Inc. Should Contact Levi & Korsinsky Before October 6, 2025 to Discuss Your RightsALT - Morningstar
Strategies to average down on Altimmune Inc.2025 Sector Review & Stock Portfolio Risk Control - Newser
Class Action Filed Against Altimmune, Inc. (ALT) Over Securities ViolationsContact Levi & Korsinsky Today - Newsfile
Activist Investor Opportunities and Corporate Governance Risks in Altimmune’s Securities Fraud Litigation - AInvest
ALT Investors Have Opportunity to Lead Altimmune, Inc. Securities Fraud Lawsuit - PR Newswire
Wellington Management Group LLP Grows Stock Holdings in Altimmune, Inc. $ALT - Defense World
Altimmune Inc. stock prediction for this weekWeekly Risk Summary & Reliable Volume Spike Trade Alerts - Newser
Developing predictive dashboards with Altimmune Inc. dataTake Profit & Expert Curated Trade Setup Alerts - Newser
Can you recover from losses in Altimmune Inc.July 2025 Pullbacks & Expert Verified Movement Alerts - Newser
ROSEN, A LEADING LAW FIRM, Encourages Altimmune, Inc. - GlobeNewswire
ROSEN, A LEADING LAW FIRM, Encourages Altimmune, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
Altimmune, Inc. (ALT) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of October 6, 2025 Deadline - ACCESS Newswire
Deutsche Bank AG Raises Position in Altimmune, Inc. $ALT - Defense World
Altimmune, Inc. $ALT Position Cut by Vanguard Group Inc. - Defense World
Shareholders that lost money on Altimmune, Inc.(ALT) should contact The Gross Law Firm about pending Class ActionALT - Eastern Progress
알티뮨 (ALT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.40%
자본화:
|
볼륨(24시간):